Recro Pharma, Inc. (REPH)

[BiotechValues]

$RPEH down 40% as if it were about to declare BK.

Yet, 2020 guidance says:

"The Company expects its Operating Income to be in the range of $5 million to $9 million and Operating income, as adjusted* to be in the range of $13 million to $17 million. EBITDA, as adjusted (Historical CDMO) to be in the range of $33 million to $37 million and EBITDA, as adjusted (Standalone)* to be in the range of $26 million to $30 million."


Took a starter today. Might take a bit to recover but I can be patient.